Maria Ines Mitrani is Chief Science Officer of Organicell Regenerative Medicine, Inc.. Currently has a direct ownership of 102 Million shares of OCEL, which is worth approximately $117 Million. The most recent transaction as insider was on May 13, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.27 per share, resulting in proceeds of $13,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102M
0% 3M change
0% 12M change
Total Value Held $117 Million

MARIA INES MITRANI Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2021
SELL
Open market or private sale
$13,500 $0.27 p/Share
50,000 Reduced 0.04%
118,330,000 Common Stock
May 12 2021
SELL
Open market or private sale
$13,000 $0.26 p/Share
50,000 Reduced 0.04%
118,380,000 Common Stock
May 11 2021
SELL
Open market or private sale
$24,000 $0.32 p/Share
75,000 Reduced 0.06%
118,430,000 Common Stock
May 10 2021
SELL
Open market or private sale
$13,500 $0.27 p/Share
50,000 Reduced 0.04%
118,505,000 Common Stock
May 07 2021
SELL
Open market or private sale
$21,600 $0.27 p/Share
80,000 Reduced 0.07%
118,555,000 Common Stock
May 06 2021
SELL
Open market or private sale
$10,400 $0.26 p/Share
40,000 Reduced 0.03%
118,635,000 Common Stock
May 05 2021
SELL
Open market or private sale
$22,500 $0.3 p/Share
75,000 Reduced 0.06%
118,675,000 Common Stock
May 04 2021
SELL
Open market or private sale
$20,000 $0.4 p/Share
50,000 Reduced 0.04%
118,750,000 Common Stock
Apr 30 2021
SELL
Open market or private sale
$23,500 $0.47 p/Share
50,000 Reduced 0.04%
118,800,000 Common Stock
Apr 06 2021
BUY
Grant, award, or other acquisition
-
5,000,000 Added 4.04%
118,850,000 Common Stock
Feb 10 2021
BUY
Grant, award, or other acquisition
-
5,000,000 Added 4.21%
113,850,000 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
5,000,000 Added 4.39%
108,850,000 Common Stock
Dec 21 2020
BUY
Grant, award, or other acquisition
-
15,000,000 Added 12.62%
103,850,000 Common Stock
Sep 23 2020
BUY
Grant, award, or other acquisition
$1,960,000 $0.28 p/Share
7,000,000 Added 8.66%
73,850,000 Common Stock
Sep 17 2020
BUY
Grant, award, or other acquisition
$150,000 $0.03 p/Share
5,000,000 Added 5.33%
88,850,000 Common Stock
Sep 03 2020
BUY
Grant, award, or other acquisition
$150,000 $0.03 p/Share
5,000,000 Added 5.63%
83,850,000 Common Stock
Aug 25 2020
BUY
Grant, award, or other acquisition
$150,000 $0.03 p/Share
5,000,000 Added 5.96%
78,850,000 Common Stock
MIM

Maria Ines Mitrani

Chief Science Officer
Miami, FL

Track Institutional and Insider Activities on OCEL

Follow Organicell Regenerative Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCEL shares.

Notify only if

Insider Trading

Get notified when an Organicell Regenerative Medicine, Inc. insider buys or sells OCEL shares.

Notify only if

News

Receive news related to Organicell Regenerative Medicine, Inc.

Track Activities on OCEL